These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 38423469)

  • 1. COVID-19 infection increases the development of Stevens-Johnson syndrome and toxic epidermal necrolysis: A retrospective cohort analysis.
    Curtis KK; Dillan MM; Sharma TR; Piktel J
    J Am Acad Dermatol; 2024 Jun; 90(6):1300-1302. PubMed ID: 38423469
    [No Abstract]   [Full Text] [Related]  

  • 2. Correlations between clinical patterns and causes of erythema multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis: results of an international prospective study.
    Auquier-Dunant A; Mockenhaupt M; Naldi L; Correia O; Schröder W; Roujeau JC;
    Arch Dermatol; 2002 Aug; 138(8):1019-24. PubMed ID: 12164739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: An Analysis of Triggers and Implications for Improving Prevention.
    Miliszewski MA; Kirchhof MG; Sikora S; Papp A; Dutz JP
    Am J Med; 2016 Nov; 129(11):1221-1225. PubMed ID: 27086495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of the acute ophthalmic manifestations of the erythema multiforme/Stevens-Johnson syndrome/toxic epidermal necrolysis disease spectrum.
    Power WJ; Ghoraishi M; Merayo-Lloves J; Neves RA; Foster CS
    Ophthalmology; 1995 Nov; 102(11):1669-76. PubMed ID: 9098260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of reporting of Stevens-Johnson syndrome and toxic epidermal necrolysis in association with selective COX-2 inhibitors.
    La Grenade L; Lee L; Weaver J; Bonnel R; Karwoski C; Governale L; Brinker A
    Drug Saf; 2005; 28(10):917-24. PubMed ID: 16180941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stevens-Johnson syndrome and toxic epidermal necrolysis at the University Hospital of the West Indies, Jamaica.
    East-Innis AD; Thompson DS
    West Indian Med J; 2013 Sep; 62(7):589-92. PubMed ID: 24831894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macrophage Activation Syndrome Complicated by Toxic Epidermal Necrolysis Following SARS-CoV-2 mRNA Vaccination.
    Franzblau LE; Mauskar M; Wysocki CA
    J Clin Immunol; 2023 Apr; 43(3):521-524. PubMed ID: 36441289
    [No Abstract]   [Full Text] [Related]  

  • 8. Incidence, outcomes, and resource use in children with Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Antoon JW; Goldman JL; Lee B; Schwartz A
    Pediatr Dermatol; 2018 Mar; 35(2):182-187. PubMed ID: 29315761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Challenges in the treatment of a patient with toxic epidermal necrolysis associated with COVID-19: A case report.
    Emadi SN; Hamzelou S; Saffarian Z; Shakoei S
    Dermatol Ther; 2021 Jan; 34(1):e14656. PubMed ID: 33301196
    [No Abstract]   [Full Text] [Related]  

  • 10. [Stevens-Johnson syndrome and toxic epidermal necrolysis: retrospective study of 185 cases in Abidjan (Côte d'Ivoire)].
    Kourouma S; Sangaré A; Kaloga M; Kouassi I; Ecra E; Gbery I; Ahogo C; Kouassi A; Kassi K; Camara B
    Med Sante Trop; 2014; 24(1):94-8. PubMed ID: 24736218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Association with Commonly Prescribed Drugs in Outpatient Care Other than Anti-Epileptic Drugs and Antibiotics: A Population-Based Case-Control Study.
    Frey N; Bodmer M; Bircher A; Jick SS; Meier CR; Spoendlin J
    Drug Saf; 2019 Jan; 42(1):55-66. PubMed ID: 30112729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medications as risk factors of Stevens-Johnson syndrome and toxic epidermal necrolysis in children: a pooled analysis.
    Levi N; Bastuji-Garin S; Mockenhaupt M; Roujeau JC; Flahault A; Kelly JP; Martin E; Kaufman DW; Maison P
    Pediatrics; 2009 Feb; 123(2):e297-304. PubMed ID: 19153164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retrospective review of drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis cases at a pediatric tertiary care institution.
    Sibbald C; Putterman E; Micheletti R; Treat J; Castelo-Soccio L
    Pediatr Dermatol; 2020 May; 37(3):461-466. PubMed ID: 32058621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous immune globulin therapy for Stevens-Johnson syndrome/toxic epidermal necrolysis complicated by hemolysis leading to pigment nephropathy and hemodialysis.
    Ririe MR; Blaylock RC; Morris SE; Jung JY
    J Am Acad Dermatol; 2013 Aug; 69(2):221-5. PubMed ID: 23673282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toxic epidermal necrolysis and co-existent SARS-CoV-2 (COVID-19) treated with intravenous immunoglobulin: 'Killing 2 birds with one stone'.
    Saha M; D'Cruz A; Paul N; Healy R; Collins D; Charles DA; Sahu S; Fonia A
    J Eur Acad Dermatol Venereol; 2021 Feb; 35(2):e97-e98. PubMed ID: 32805059
    [No Abstract]   [Full Text] [Related]  

  • 16. Assessing carbamazepine and oxcarbazepine-associated Stevens-Johnson syndrome/toxic epidermal necrolysis: Data mining the public version of the FDA adverse event reporting system.
    Xu C; Pan L; Zhang Y; Zhang J; Sun Q; Fang W
    Int J Clin Pract; 2021 Aug; 75(8):e14273. PubMed ID: 33908133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of Stevens-Johnson syndrome and toxic epidermal necrolysis in children.
    Prendiville JS; Hebert AA; Greenwald MJ; Esterly NB
    J Pediatr; 1989 Dec; 115(6):881-7. PubMed ID: 2585222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenytoin induced Stevens-Johnson Syndrome-toxic Epidermal Necrolysis Overlap Exacerbated by Cephalexin in a 65-Year-old Neurosurgical Patient: A Rare Case Report.
    Rathinam KK; Sabarathinam S; Nuthalapati P; Mahalingam VT
    Curr Drug Res Rev; 2022; 14(1):80-83. PubMed ID: 34225642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Case report: psychosis with Stevens-Johnson syndrome and toxic epidermal necrolysis.
    de Rego JA; Goldstein DM
    Hillside J Clin Psychiatry; 1985; 7(2):141-8. PubMed ID: 4077031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute respiratory failure in patients with toxic epidermal necrolysis: clinical features and factors associated with mechanical ventilation.
    de Prost N; Mekontso-Dessap A; Valeyrie-Allanore L; Van Nhieu JT; Duong TA; Chosidow O; Wolkenstein P; Brun-Buisson C; Maître B
    Crit Care Med; 2014 Jan; 42(1):118-28. PubMed ID: 23989174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.